A5102705943- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Diabetes Management and Research
- COVID-19 epidemiological studies
- Chronic Disease Management Strategies
- Diabetes and associated disorders
- Analytical Methods in Pharmaceuticals
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Climate Change and Health Impacts
- Analytical Chemistry and Chromatography
- Health and Well-being Studies
- Antibiotics Pharmacokinetics and Efficacy
Shiraz University of Medical Sciences
2020-2021
Islamic Azad University North Tehran Branch
2015-2020
Introduction A life-threatening respiratory disease, coronavirus 2019 (COVID-19), has spread across the globe since December 2019. Many prognostic factors have already been put forward to predict risk of death and other outcomes. The current study is evaluating survival rate between hypertensive non-hypertensive infected patients.
Emergence of a new coronavirus causes serious concern whether this can be stopped at all. The ongoing disease created substantial variation in the fatality rate over world. current report brought an explore about epidemiological characteristics deceased patients and after first peak Fars province which is fourth most populous large Iran. Of 3702 confirmed cases with coVID-19, 87 passed away so estimated 2.35. Also, it was derived that male sex, old age underlying diseases especially diabetes...
BackgroundCardiovascular diseases are the leading cause of death worldwide, and myocardial infarction is one common manifestations these diseases. The goal this study was to compare survival rate patients treated with thrombolysis PPCI in STEMI.MethodThis a analysis performed on 354 Shiraz, Iran. Admission time considered as starting point or last follow-up endpoint. All cases STEMI were reviewed from beginning end 2018. Data collected using checklist telephone call they analyzed Log Rank...
Abstract Objective: A year after the emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as new crisis in infections, there remain many uncertainties and unknowns about SARS-CoV-2 disease it causes, called ( COVID-19 ). Although is known disease, some atypical manifestations have been seen, different from those seen other types viral infections. This paper aims to describe designing, launching, implementing data collection system for all diseases,...
Abstract Purpose: According to the possible role of other comorbidities in increase risk mortality diabetes patient, recent study was designed manage complications and rate this group patients. Methods: In cross-sectional (25 February 10 July 2020) total 458 diabetic patients were enrolled based on their characteristics, symptoms signs, presence underlying diseases. Multiple logistic regression χ2 test analysis used check effectiveness outcome among Results: Of patients, 306 (67%) with...